{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:02:07Z","timestamp":1761490927244,"version":"build-2065373602"},"reference-count":21,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ncRNA"],"abstract":"<jats:p>Testicular germ cell tumors (TGCTs) are the most commonly diagnosed malignancies in younger men. The monitoring of disease course and recurrence is supported by traditional tumor markers, including \u03b1-fetoprotein (AFP). AFP is physiologically synthesized in the liver and can be detected at increased levels in testicular cancer patients as well as under other benign liver diseases, which have been reported as a misleading cause of interpretation of TGCTs clinical course. A cluster of stem cell-associated microRNAs has been reported to outperform traditional tumor markers in newly diagnosed TGCTs, but the value of these microRNAs to differentiate between specific and unspecific AFP elevations, has never been reported. We report here a patient with chronic hepatitis B and normal liver related blood values presenting with a surgically removed primary TGCT and elevated AFP levels. Clinical staging revealed a suspect retroperitoneal metastatic lymph node together with other risk factors and first line treatment with PEB chemotherapy was administered. During curative treatment significantly rising AFP levels led to the assumption of chemo-resistant disease, mandating the initiation of salvage chemotherapy and surgical removal of the putative lymph node metastases. The AFP levels continuously decreased with the interruption of chemotherapeutic agents, indicating a chemotherapy-induced liver toxicity on the basis of pre-existing liver disease. MiR-371a-3p serum levels were not detectable in serum samples with elevated AFP levels. In conclusion, miR-371a-3p may be a reliable biomarker to differentiate between non-specific AFP elevations in TGCTs patients.<\/jats:p>","DOI":"10.3390\/ncrna6010002","type":"journal-article","created":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T04:43:03Z","timestamp":1578026583000},"page":"2","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["MicroRNAs as Appropriate Discriminators in Non-Specific Alpha-Fetoprotein (AFP) Elevation in Testicular Germ Cell Tumor Patients"],"prefix":"10.3390","volume":"6","author":[{"given":"Anna L.","family":"Lembeck","sequence":"first","affiliation":[{"name":"Division of Oncology, Medical University of Graz, 8036 Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Puchas","sequence":"additional","affiliation":[{"name":"Division of Oncology, Medical University of Graz, 8036 Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Hutterer","sequence":"additional","affiliation":[{"name":"Department of Urology, Medical University of Graz, 8036 Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0812-3024","authenticated-orcid":false,"given":"Dominik A.","family":"Barth","sequence":"additional","affiliation":[{"name":"Division of Oncology, Medical University of Graz, 8036 Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelika","family":"Terbuch","sequence":"additional","affiliation":[{"name":"Division of Oncology, Medical University of Graz, 8036 Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9124-4876","authenticated-orcid":false,"given":"Thomas","family":"Bauernhofer","sequence":"additional","affiliation":[{"name":"Division of Oncology, Medical University of Graz, 8036 Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8701-9462","authenticated-orcid":false,"given":"Martin","family":"Pichler","sequence":"additional","affiliation":[{"name":"Division of Oncology and Research Unit for Non-Coding RNA and Genome Editing, Medical University of Graz, 8036 Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,1,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA A Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/andr.293","article-title":"International patterns and trends in testicular cancer incidence, overall and by histologic subtype, 1973\u20132007","volume":"3","author":"Trabert","year":"2015","journal-title":"Andrology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.eururo.2017.09.025","article-title":"Testicular Tumor Size and Rete Testis Invasion as Prognostic Factors for the Risk of Relapse of Clinical Stage I Seminoma Testis Patients Under Surveillance: A Systematic Review by the Testicular Cancer Guidelines Panel","volume":"73","author":"Boormans","year":"2018","journal-title":"Eur. Urol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1200\/JCO.2017.73.4723","article-title":"Practice Makes Perfect: The Rest of the Story in Testicular Cancer as a Model Curable Neoplasm","volume":"35","author":"Tandstad","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1464-410X.1997.27517.x","article-title":"The role of tumor markers in the diagnosis and treatment of testicular germ cell cancers","volume":"79","author":"Doherty","year":"1997","journal-title":"Br. J. Urol."},{"key":"ref_6","first-page":"1","article-title":"Role of biochemical markers in testicular cancer: Diagnosis, staging, and surveillance","volume":"4","author":"Milose","year":"2011","journal-title":"J. Urol."},{"key":"ref_7","first-page":"979","article-title":"Synthesis of -fetoprotein by liver, yolk sac, and gastrointestinal tract of the human conceptus","volume":"32","author":"Gitlin","year":"1972","journal-title":"Cancer Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1002\/1097-0142(19931015)72:8<2491::AID-CNCR2820720829>3.0.CO;2-0","article-title":"False elevations of alpha-fetoprotein associated with liver dysfunction in germ cell tumors","volume":"72","author":"Llanos","year":"1993","journal-title":"Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1046\/j.1440-1746.1999.01873.x","article-title":"Role of alpha-fetoprotein in the diagnosis and management of hepatocellular carcinoma","volume":"14","author":"Johnson","year":"1999","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-3-319-74470-4_6","article-title":"MicroRNAs, Regulatory Messengers Inside and Outside Cancer Cells","volume":"1056","author":"Anfossi","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.cell.2018.07.040","article-title":"SnapShot: Unconventional miRNA Functions","volume":"174","author":"Dragomir","year":"2018","journal-title":"Cell"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000477446","article-title":"Serum Levels of MicroRNA371a-3p: A Highly Sensitive Tool for Diagnosing and Staging Testicular Germ Cell Tumors: A Clinical Case Series","volume":"99","author":"Anheuser","year":"2017","journal-title":"Urol. Int."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ucl.2015.08.013","article-title":"MicroRNAs in Testicular Cancer Diagnosis and Prognosis","volume":"43","author":"Ling","year":"2016","journal-title":"Urol. Clin. North Am."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1200\/JCO.18.01480","article-title":"Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study","volume":"37","author":"Dieckmann","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Terbuch, A., Adiprasito, J.B., Stiegelbauer, V., Seles, M., Klec, C., Pichler, G.P., Resel, M., Posch, F., Lembeck, A.L., and St\u00f6ger, H. (2018). MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19103130"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.eururo.2012.02.037","article-title":"Serum Levels of MicroRNAs miR-371-3: A Novel Class of Serum Biomarkers for Testicular Germ Cell Tumors?","volume":"61","author":"Belge","year":"2012","journal-title":"Eur. Urol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1038\/bjc.2012.469","article-title":"MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumors","volume":"107","author":"Dieckmann","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.molonc.2013.08.002","article-title":"Targeted serum miRNA (TSmiR) test for diagnosis and follow-up of (testicular) germ cell cancer patients: A proof of principle","volume":"7","author":"Gillis","year":"2013","journal-title":"Mol. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1158\/0008-5472.CAN-09-3301","article-title":"Malignant germ cell tumors display common microRNA profiles resulting in global changes in expression of messenger RNA targets","volume":"70","author":"Palmer","year":"2010","journal-title":"Cancer Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3389\/fgene.2019.00463","article-title":"Quantitative PCR Measurement of miR-371a-3p and miR-372-p Is Influenced by Hemolysis","volume":"10","author":"Myklebust","year":"2019","journal-title":"Front. Genet."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/s41598-019-38505-x","article-title":"Normalization strategies differently affect circulating miRNA profile associated with the training status","volume":"9","author":"Faraldi","year":"2019","journal-title":"Sci. Rep."}],"container-title":["Non-Coding RNA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2311-553X\/6\/1\/2\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:42:04Z","timestamp":1760362924000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2311-553X\/6\/1\/2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,1]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,3]]}},"alternative-id":["ncrna6010002"],"URL":"https:\/\/doi.org\/10.3390\/ncrna6010002","relation":{},"ISSN":["2311-553X"],"issn-type":[{"type":"electronic","value":"2311-553X"}],"subject":[],"published":{"date-parts":[[2020,1,1]]}}}